Search for: "Bayer Corp" Results 461 - 480 of 505
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Aug 2010, 10:14 pm
Bayer Bioscience N.V., 514 F.3d 1229, 1239-40 (Fed. [read post]
23 Jan 2015, 9:30 am
Bayer Corp., 727 F.3d 300 (3d Cir. 2013), and Marcus v. [read post]
22 Oct 2009, 2:59 pm
(yo-yo) and Otis Elevator Corp. [read post]
17 Apr 2008, 10:39 am
Novartis Pharmaceuticals Corp., ___ F. [read post]
31 Oct 2012, 11:00 pm by Paul Karlsgodt
Bayer Corporation calling into question whether a plaintiff can do anything to bind the members of a putative class before it is certified. [read post]
17 Jun 2011, 6:25 am by Victoria VanBuren
See In re Empire Pipeline Corp., 323 S.W.3d 308, 315 (Tex. [read post]
4 Dec 2006, 7:11 am
In 2005, a federal judge in New York dismissed a lawsuit by Bayer investors after noting that just 8 percent of the German company's shares are traded in the United States. [read post]
19 Sep 2008, 6:00 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
27 Jun 2008, 10:04 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences: (Managing… [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
29 Dec 2011, 6:53 am by Bexis
Happy Christmas/Hanukkah/solstice and Merry New Year to all our readers. [read post]